Guidelines on Testicular Cancer: 2015 Update

Standard

Guidelines on Testicular Cancer: 2015 Update. / Albers, Peter; Albrecht, Walter; Algaba, Ferran; Bokemeyer, Carsten; Cohn-Cedermark, Gabriella; Fizazi, Karim; Horwich, Alan; Laguna, Maria Pilar; Nicolai, Nicola; Oldenburg, Jan.

In: EUR UROL, Vol. 68, No. 6, 12.2015, p. 1054-68.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Albers, P, Albrecht, W, Algaba, F, Bokemeyer, C, Cohn-Cedermark, G, Fizazi, K, Horwich, A, Laguna, MP, Nicolai, N & Oldenburg, J 2015, 'Guidelines on Testicular Cancer: 2015 Update', EUR UROL, vol. 68, no. 6, pp. 1054-68. https://doi.org/10.1016/j.eururo.2015.07.044

APA

Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K., Horwich, A., Laguna, M. P., Nicolai, N., & Oldenburg, J. (2015). Guidelines on Testicular Cancer: 2015 Update. EUR UROL, 68(6), 1054-68. https://doi.org/10.1016/j.eururo.2015.07.044

Vancouver

Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K et al. Guidelines on Testicular Cancer: 2015 Update. EUR UROL. 2015 Dec;68(6):1054-68. https://doi.org/10.1016/j.eururo.2015.07.044

Bibtex

@article{8dd6ecf10a954c53ad3fa59a46f58565,
title = "Guidelines on Testicular Cancer: 2015 Update",
abstract = "CONTEXT: This is an update of the previous European Association of Urology testis cancer guidelines published in 2011, which included major changes in the diagnosis and treatment of germ cell tumours.OBJECTIVE: To summarise latest developments in the treatment of this rare disease. Recommendations have been agreed within a multidisciplinary working group consisting of urologists, medical oncologists, and radiation oncologists.EVIDENCE ACQUISITION: A semi-structured literature search up to February 2015 was performed to update the recommendations. In addition, this document was subjected to double-blind peer review before publication.EVIDENCE SYNTHESIS: This publication focuses on the most important changes in treatment recommendations for clinical stage I disease and the updated recommendations for follow-up.CONCLUSIONS: Most changes in the recommendations will lead to an overall reduction in treatment burden for patients with germ cell tumours. In advanced stages, treatment intensification is clearly defined to further improve overall survival rates.PATIENT SUMMARY: This is an update of a previously published version of the European Association of Urology guidelines for testis cancer, and includes new recommendations for clinical stage I disease and revision of the follow-up recommendations. Patients should be fully informed of all the treatment options available to them.",
author = "Peter Albers and Walter Albrecht and Ferran Algaba and Carsten Bokemeyer and Gabriella Cohn-Cedermark and Karim Fizazi and Alan Horwich and Laguna, {Maria Pilar} and Nicola Nicolai and Jan Oldenburg",
note = "Copyright {\textcopyright} 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.",
year = "2015",
month = dec,
doi = "10.1016/j.eururo.2015.07.044",
language = "English",
volume = "68",
pages = "1054--68",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "6",

}

RIS

TY - JOUR

T1 - Guidelines on Testicular Cancer: 2015 Update

AU - Albers, Peter

AU - Albrecht, Walter

AU - Algaba, Ferran

AU - Bokemeyer, Carsten

AU - Cohn-Cedermark, Gabriella

AU - Fizazi, Karim

AU - Horwich, Alan

AU - Laguna, Maria Pilar

AU - Nicolai, Nicola

AU - Oldenburg, Jan

N1 - Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.

PY - 2015/12

Y1 - 2015/12

N2 - CONTEXT: This is an update of the previous European Association of Urology testis cancer guidelines published in 2011, which included major changes in the diagnosis and treatment of germ cell tumours.OBJECTIVE: To summarise latest developments in the treatment of this rare disease. Recommendations have been agreed within a multidisciplinary working group consisting of urologists, medical oncologists, and radiation oncologists.EVIDENCE ACQUISITION: A semi-structured literature search up to February 2015 was performed to update the recommendations. In addition, this document was subjected to double-blind peer review before publication.EVIDENCE SYNTHESIS: This publication focuses on the most important changes in treatment recommendations for clinical stage I disease and the updated recommendations for follow-up.CONCLUSIONS: Most changes in the recommendations will lead to an overall reduction in treatment burden for patients with germ cell tumours. In advanced stages, treatment intensification is clearly defined to further improve overall survival rates.PATIENT SUMMARY: This is an update of a previously published version of the European Association of Urology guidelines for testis cancer, and includes new recommendations for clinical stage I disease and revision of the follow-up recommendations. Patients should be fully informed of all the treatment options available to them.

AB - CONTEXT: This is an update of the previous European Association of Urology testis cancer guidelines published in 2011, which included major changes in the diagnosis and treatment of germ cell tumours.OBJECTIVE: To summarise latest developments in the treatment of this rare disease. Recommendations have been agreed within a multidisciplinary working group consisting of urologists, medical oncologists, and radiation oncologists.EVIDENCE ACQUISITION: A semi-structured literature search up to February 2015 was performed to update the recommendations. In addition, this document was subjected to double-blind peer review before publication.EVIDENCE SYNTHESIS: This publication focuses on the most important changes in treatment recommendations for clinical stage I disease and the updated recommendations for follow-up.CONCLUSIONS: Most changes in the recommendations will lead to an overall reduction in treatment burden for patients with germ cell tumours. In advanced stages, treatment intensification is clearly defined to further improve overall survival rates.PATIENT SUMMARY: This is an update of a previously published version of the European Association of Urology guidelines for testis cancer, and includes new recommendations for clinical stage I disease and revision of the follow-up recommendations. Patients should be fully informed of all the treatment options available to them.

U2 - 10.1016/j.eururo.2015.07.044

DO - 10.1016/j.eururo.2015.07.044

M3 - SCORING: Journal article

C2 - 26297604

VL - 68

SP - 1054

EP - 1068

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 6

ER -